Authors: Dowsett, M Archer, A Assersohn, L Gregory, RK Ellis, PA Salter, J Chang, J Mainwaring, P Boeddinghaus, I Johnston, SRD Powles, TJ Smith, IE

Citation: M. Dowsett et al., Clinical studies of apoptosis and proliferation in breast cancer, ENDOCR-R CA, 6(1), 1999, pp. 25-28

Authors: Assersohn, L Webb, A Cunningham, D Ross, P Smith, A Norman, A Hey, L

Citation: L. Assersohn et al., Effect of stomatitis on patients treated with adjuvant 5-fluorouracil and folinic acid for colorectal carcinoma, GI CANCER, 3(1), 1999, pp. 61-66

Authors: Assersohn, L Powles, TJ Ashley, S Nash, AG Neal, AJ Sacks, N Chang, J della Rovere, UQ Naziri, N

Citation: L. Assersohn et al., Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy, ANN ONCOL, 10(12), 1999, pp. 1451-1455

Authors: Chang, J Powles, TJ Allred, DC Ashey, SE Clark, GM Makris, A Assersohn, L Gregory, RK Osborne, CK Dowsett, M

Citation: J. Chang et al., Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer, J CL ONCOL, 17(10), 1999, pp. 3058-3063

Authors: Assersohn, L Norman, A Cunningham, D Benepal, T Ross, PJ Oates, J

Citation: L. Assersohn et al., Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma, BR J CANC, 79(11-12), 1999, pp. 1800-1805